NCT00141401View on ClinicalTrials.gov

Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

July 31, 2005

Conditions
Diabetic Neuropathy, Painful
Interventions
DRUG

Pregabalin

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY